Carlsmed (CARL) EV to FCF (2025 - 2026)

Carlsmed's (CARL) quarterly EV to FCF came in at 21.2 in Q2 2026, down 122.94% quarter-over-quarter from 9.51 in Q1 2026.

Analysis

Carlsmed (CARL) EV to FCF (2025 - 2026) Analysis & Trends

Carlsmed (CARL) has reported EV to FCF for 2 consecutive years, with 21.2 the latest figure, recorded in Q2 2026.

For the quarter ending Q2 2026, EV to FCF changed N/A year-over-year to 21.2; the trailing twelve-month figure through Jun 2026 stood at 4.81 (changed N/A YoY), and the FY2025 full-year result was 2.22, changed N/A from the prior year.
EV to FCF slipped to 21.2 in Q2 2026 per CARL's latest filing, from 9.51 in the prior quarter.
Across five years, EV to FCF topped out at 9.51 in Q1 2026 and bottomed at 21.2 in Q2 2026.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	187.42 Bn	182.47 Bn	7.27 Bn
2	Intuitive Surgical	129.78 Bn	124.69 Bn	1.96 Bn
3	Medtronic	120.53 Bn	112.33 Bn	6.34 Bn
4	Stryker	116.28 Bn	112.80 Bn	4.50 Bn
5	Boston Scientific	69.29 Bn	68.99 Bn	3.85 Bn
6	Edwards Lifesciences	51.83 Bn	47.68 Bn	1.35 Bn
7	Alcon	34.36 Bn	32.91 Bn	1.68 Bn
8	Dexcom	33.17 Bn	31.23 Bn	830.00 Mn
9	Resmed	32.94 Bn	31.47 Bn	861.22 Mn
10	Carlsmed	424.72 Mn	311.42 Mn	14.54 Mn

Historic Data

Download Data